Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,716
Closed -$212K 1394
2024
Q1
$212K Sell
2,716
-134
-5% -$9.97K ﹤0.01% 1283
2023
Q4
$204K Buy
+2,850
New +$198K ﹤0.01% 1257
2023
Q3
Sell
-2,707
Closed -$219K 1353
2023
Q2
$219K Buy
2,707
+42
+2% +$3.43K ﹤0.01% 1214
2023
Q1
$215K Buy
+2,665
New +$215K ﹤0.01% 1205
2022
Q3
Sell
-3,225
Closed -$223K 1316
2022
Q2
$223K Hold
3,225
﹤0.01% 1133
2022
Q1
$248K Sell
3,225
-300
-9% -$21.6K ﹤0.01% 1138
2021
Q4
$270K Hold
3,525
﹤0.01% 1086
2021
Q3
$260K Buy
+3,525
New +$264K ﹤0.01% 1067
2019
Q2
Sell
-5,826
Closed -$282K 1068
2019
Q1
$282K Sell
5,826
-512
-8% -$23.1K ﹤0.01% 908
2018
Q4
$260K Sell
6,338
-1,325
-17% -$54.4K 0.01% 870
2018
Q3
$314K Buy
7,663
+904
+13% +$36.5K 0.01% 893
2018
Q2
$269K Buy
6,759
+273
+4% +$10.5K 0.01% 919
2018
Q1
$242K Buy
+6,486
New +$262K 0.01% 927
2017
Q3
Sell
-1,550
Closed -$70K 1482
2017
Q2
$70K Hold
1,550
﹤0.01% 1406
2017
Q1
$65K Buy
1,550
+251
+19% +$10.2K ﹤0.01% 1412
2016
Q4
$52K Sell
1,299
-126
-9% -$4.86K ﹤0.01% 1576
2016
Q3
$54K Hold
1,425
﹤0.01% 1487
2016
Q2
$49K Buy
1,425
+89
+7% +$3.08K ﹤0.01% 1424
2016
Q1
$46K Buy
+1,336
New +$46.6K ﹤0.01% 1419
2015
Q4
Sell
-36
Closed -$1K 2245
2015
Q3
$1K Sell
36
-1,754
-98% -$69.6K ﹤0.01% 2143
2015
Q2
$67K Sell
1,790
-311
-15% -$10.9K ﹤0.01% 1308
2015
Q1
$68K Buy
2,101
+700
+50% +$21.5K ﹤0.01% 1295
2014
Q4
$36K Buy
1,401
+572
+69% +$14.8K ﹤0.01% 1534
2014
Q3
$19K Buy
829
+99
+14% +$2.5K ﹤0.01% 1681
2014
Q2
$17K Hold
730
﹤0.01% 1689
2014
Q1
$14K Buy
730
+292
+67% +$6.3K ﹤0.01% 1723
2013
Q4
$8K Buy
438
+50
+13% +$1.1K ﹤0.01% 1777
2013
Q3
$7K Hold
388
﹤0.01% 1526
2013
Q2
$7K Buy
+388
New +$8.11K ﹤0.01% 1478

Other funds holding HOLX

D.A. Davidson & Co's HOLX Position: Q2 2024 in Review

D.A. Davidson & Co sold out of Hologic (HOLX) in Q2 2024, closing a stake of 2,716 shares — an estimated $212K sold.

D.A. Davidson & Co first reported a position in HOLX in Q2 2013 and held it in 29 quarters. The position peaked at $314K in Q3 2018. 702 funds tracked by Wall St. Rank hold HOLX as of Q2 2024.

  • D.A. Davidson & Co reported no remaining Hologic position as of Q2 2024 after selling out during the quarter.
  • D.A. Davidson & Co sold 2,716 Hologic shares in Q2 2024, an estimated $212K.
  • D.A. Davidson & Co first reported a position in Hologic in Q2 2013 and held it in 29 quarters.
  • D.A. Davidson & Co's Hologic position peaked at $314K in Q3 2018.
  • 702 funds tracked by Wall St. Rank held Hologic as of Q2 2024.

Based on D.A. Davidson & Co's 13F filing for Q2 2024, filed 1 Aug 2024.